Cysteinyl Leukotrienes and 8-isoprostane in Exhaled Breath Condensate of Children with Asthma Exacerbations

Overview

Journal Thorax

Date 2003 May 31

PMID 12775861

Citations 55

Authors

E Baraldi

S Carraro

R Alinovi

A Pesci

L Ghiro

A Bodini

G Piacentini

F Zacchello

S Zanconato

Affiliations

Soon will be listed here.

Abstract

Background: Cysteinyl leukotrienes (Cys-LTs) and isoprostanes are inflammatory metabolites derived from arachidonic acid whose levels are increased in the airways of asthmatic patients. Isoprostanes are relatively stable and specific for lipid peroxidation, which makes them potentially reliable biomarkers for oxidative stress. A study was undertaken to evaluate the effect of a course of oral steroids on Cys-LT and 8-isoprostane levels in exhaled breath condensate of children with an asthma exacerbation.

Methods: Exhaled breath condensate was collected and fractional exhaled nitric oxide (FE(NO)) and spirometric parameters were measured before and after a 5 day course of oral prednisone (1 mg/kg/day) in 15 asthmatic children with an asthma exacerbation. Cys-LT and 8-isoprostane concentrations were measured using an enzyme immunoassay. FE(NO) was measured using a chemiluminescence analyser. Exhaled breath condensate was also collected from 10 healthy children.

Results: Before prednisone treatment both Cys-LT and 8-isoprostane concentrations were higher in asthmatic subjects (Cys-LTs, 12.7 pg/ml (IQR 5.4-15.6); 8-isoprostane, 12.0 pg/ml (9.4-29.5)) than in healthy children (Cys-LTs, 4.3 pg/ml (2.0-5.7), p=0.002; 8-isoprostane, 2.6 pg/ml (2.1-3.0), p<0.001). After prednisone treatment there was a significant decrease in both Cys-LT (5.2 pg/ml (3.9-8.8), p=0.005) and 8-isoprostane (8.4 pg/ml (5.4-11.6), p=0.04) concentrations, but 8-isoprostane levels remained higher than in controls (p<0.001). FE(NO) levels, which fell significantly after prednisone treatment (p<0.001), did not correlate significantly with either Cys-LT or 8-isoprostane concentrations.

Conclusion: After a 5 day course of oral prednisone there is a reduction in Cys-LT and 8-isoprostane levels in EBC of children with an asthma exacerbation, although 8-isoprostane levels remain higher than in controls. This finding suggests that corticosteroids may not be fully effective in reducing oxidative stress in children with an exacerbation of asthma.

Citing Articles

Angiogenesis Factors as Emerging Circulating Biomarkers in Asthma.

Lee P, An M, Jang A Allergy Asthma Immunol Res. 2025; 17(1):22-31.

PMID: 39895600 PMC: 11791373. DOI: 10.4168/aair.2025.17.1.22.

Breath and Sputum Analyses in Asthmatic Patients: An Overview.

Soccio P, Quarato C, Tondo P, Lacedonia D, Hoxhallari A, Foschino Barbaro M Cells. 2024; 13(16).

PMID: 39195245 PMC: 11353195. DOI: 10.3390/cells13161355.

The Role of Exhaled Breath Condensate in Chronic Inflammatory and Neoplastic Diseases of the Respiratory Tract.

Kita K, Gawinowska M, Chelminska M, Niedoszytko M Int J Mol Sci. 2024; 25(13).

PMID: 39000502 PMC: 11242091. DOI: 10.3390/ijms25137395.

Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons.

Hussain M, Liu G Cells. 2024; 13(5.

PMID: 38474348 PMC: 10931088. DOI: 10.3390/cells13050384.

Impact of Climate Change on Dietary Nutritional Quality and Implications for Asthma and Allergy.

Carroll K Immunol Allergy Clin North Am. 2023; 44(1):85-96.

PMID: 37973262 PMC: 11233177. DOI: 10.1016/j.iac.2023.09.002.

References

Jobsis Q, Raatgeep H, Schellekens S, Kroesbergen A, Hop W, de Jongste J . Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J. 2000; 16(1):95-100. DOI: 10.1034/j.1399-3003.2000.16a17.x. View

MacFarlane A, Dworski R, Sheller J, Pavord I, Kay A, Barnes N . Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. Am J Respir Crit Care Med. 2000; 161(5):1553-8. DOI: 10.1164/ajrccm.161.5.9906068. View

Wood L, Fitzgerald D, Gibson P, Cooper D, Garg M . Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids. 2000; 35(9):967-74. DOI: 10.1007/s11745-000-0607-x. View

Hanazawa T, Kharitonov S, Barnes P . Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med. 2000; 162(4 Pt 1):1273-6. DOI: 10.1164/ajrccm.162.4.9912064. View

Bisgaard H . Leukotriene modifiers in pediatric asthma management. Pediatrics. 2001; 107(2):381-90. DOI: 10.1542/peds.107.2.381. View

Kharitonov S, Barnes P . Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001; 163(7):1693-722. DOI: 10.1164/ajrccm.163.7.2009041. View

Mutlu G, Garey K, Robbins R, Danziger L, Rubinstein I . Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med. 2001; 164(5):731-7. DOI: 10.1164/ajrccm.164.5.2101032. View

Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S . pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med. 2002; 165(10):1364-70. DOI: 10.1164/rccm.200111-068OC. View

Hunt J . Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol. 2002; 110(1):28-34. DOI: 10.1067/mai.2002.124966. View

10.

Csoma Z, Kharitonov S, Balint B, Bush A, Wilson N, Barnes P . Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med. 2002; 166(10):1345-9. DOI: 10.1164/rccm.200203-233OC. View

11.

Kaneko Y, Floras J, Usui K, Plante J, Tkacova R, Kubo T . Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003; 348(13):1233-41. DOI: 10.1056/NEJMoa022479. View

12.

Bland J, Altman D . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476):307-10. View

13.

Wardlaw A, Hay H, Cromwell O, Collins J, Kay A . Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol. 1989; 84(1):19-26. DOI: 10.1016/0091-6749(89)90173-5. View

14.

Wenzel S, Larsen G, Johnston K, Voelkel N, Westcott J . Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis. 1990; 142(1):112-9. DOI: 10.1164/ajrccm/142.1.112. View

15.

Dworski R, FitzGerald G, OATES J, Sheller J . Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med. 1994; 149(4 Pt 1):953-9. DOI: 10.1164/ajrccm.149.4.8143061. View

16.

Crocker I, Zhou C, Bewtra A, Kreutner W, Townley R . Glucocorticosteroids inhibit leukotriene production. Ann Allergy Asthma Immunol. 1997; 78(5):497-505. DOI: 10.1016/S1081-1206(10)63238-3. View

17.

Oosaki R, Mizushima Y, Kawasaki A, Kashii T, Mita H, Shida T . Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks. Int Arch Allergy Immunol. 1997; 114(4):373-8. DOI: 10.1159/000237697. View

18.

Shindo K, Machida M, Fukumura M, Koide K . Prednisolone inhibits synthesis of 5-H(P)ETE in eosinophils from asthmatic patients during a wheezing attack but not during remission. Prostaglandins Leukot Essent Fatty Acids. 1998; 58(2):111-7. DOI: 10.1016/s0952-3278(98)90149-1. View

19.

Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov S, Barnes P . Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med. 1999; 160(1):216-20. DOI: 10.1164/ajrccm.160.1.9809140. View

20.

Hood P, COTTER T, Costello J, Sampson A . Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients. Thorax. 1999; 54(12):1075-82. PMC: 1763762. DOI: 10.1136/thx.54.12.1075. View